328 related articles for article (PubMed ID: 7865899)
21. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
Chiang MY; Chan H; Zounes MA; Freier SM; Lima WF; Bennett CF
J Biol Chem; 1991 Sep; 266(27):18162-71. PubMed ID: 1680858
[TBL] [Abstract][Full Text] [Related]
22. Analysis of RNA-protein complexes by oligonucleotide-targeted RNase H digestion.
Günzl A; Palfi Z; Bindereif A
Methods; 2002 Feb; 26(2):162-9. PubMed ID: 12054893
[TBL] [Abstract][Full Text] [Related]
23. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
[TBL] [Abstract][Full Text] [Related]
24. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
25. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism for suppression mRNA translation with antisense oligonucleotides].
Vlasov VV; Iurchenko LV
Mol Biol (Mosk); 1990; 24(5):1157-61. PubMed ID: 2290415
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
[TBL] [Abstract][Full Text] [Related]
29. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
30. Oligonucleotide-based knockdown technologies: antisense versus RNA interference.
Achenbach TV; Brunner B; Heermeier K
Chembiochem; 2003 Oct; 4(10):928-35. PubMed ID: 14523910
[TBL] [Abstract][Full Text] [Related]
31. Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes.
Crooke ST; Lemonidis KM; Neilson L; Griffey R; Lesnik EA; Monia BP
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):599-608. PubMed ID: 8526876
[TBL] [Abstract][Full Text] [Related]
32. A phosphorothioate oligonucleotide blocks reverse transcription via an antisense mechanism.
Boiziau C; Moreau S; Toulmé JJ
FEBS Lett; 1994 Mar; 340(3):236-40. PubMed ID: 7510640
[TBL] [Abstract][Full Text] [Related]
33. Degradation of FinP antisense RNA from F-like plasmids: the RNA-binding protein, FinO, protects FinP from ribonuclease E.
Jerome LJ; van Biesen T; Frost LS
J Mol Biol; 1999 Jan; 285(4):1457-73. PubMed ID: 9917389
[TBL] [Abstract][Full Text] [Related]
34. Chemically modified oligonucleotides with efficient RNase H response.
Vester B; Boel AM; Lobedanz S; Babu BR; Raunkjaer M; Lindegaard D; Raunak ; Hrdlicka PJ; Højland T; Sharma PK; Kumar S; Nielsen P; Wengel J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2296-300. PubMed ID: 18356048
[TBL] [Abstract][Full Text] [Related]
35. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
36. Antisense-mediated specific inhibition of P120 protein expression prevents G1- to S-phase transition.
Fonagy A; Swiderski C; Dunn M; Freeman JW
Cancer Res; 1992 Oct; 52(19):5250-6. PubMed ID: 1394129
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
[TBL] [Abstract][Full Text] [Related]
38. Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme.
Denman RB; Smedman M; Abraham M; Chen-Hwang MC; Currie JR
Arch Biochem Biophys; 1997 Dec; 348(1):82-90. PubMed ID: 9390177
[TBL] [Abstract][Full Text] [Related]
39. Myotonic dystrophy: antisense oligonucleotide inhibition of DMPK gene expression in vitro.
Galderisi U; Cipollaro M; Melone MA; Iacomino G; Di Bernardo G; Galano G; Contrufo R; Zappia V; Cascino A
Biochem Biophys Res Commun; 1996 Apr; 221(3):750-4. PubMed ID: 8630033
[TBL] [Abstract][Full Text] [Related]
40. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
